MALVERN, Pa., March 15, 2018 /PRNewswire/ — Ocugen, Inc., a rapidly growing ophthalmology company developing a rich clinical pipeline of innovative therapies that address rare and underserved ocular diseases, today announced that it will present at the Oppenheimer & Co. 28th Annual…
